Feasibility of using O-18 for PET proton range verification

Slides:



Advertisements
Similar presentations
Harvard Medical School Massachusetts General Hospital.
Advertisements

Results/Discussion cont’d. Excluding data past the depth of 10% dose, 91% of points passed. A trend towards over-response was noted in the BANG3-Pro2 dosimeter.
Energy deposition and neutron background studies for a low energy proton therapy facility Roxana Rata*, Roger Barlow* * International Institute for Accelerator.
Experience, Expertise and a Commitment to Excellence™
Alexander Klyachko, IU Cyclotron, PTCOG51, Seoul, South Korea, May 17-19, 2012 A.V. Klyachko 1, D.F. Nichiporov 1, L. Coutinho 2, C.-W. Cheng 2, 3, M.
University of Florida, Jacksonville, FL
Tumour Therapy with Particle Beams Claus Grupen University of Siegen, Germany [physics/ ] Phy 224B Chapter 20: Applications of Nuclear Physics 24.
Lotte Verbunt Investigation of leaf positioning accuracy of two types of Siemens MLCs making use of an EPID.
Interactions of charged particles with the patient I.The depth-dose distribution - How the Bragg Peak comes about - (Thomas Bortfeld) II.The lateral dose.
Tissue inhomogeneities in Monte Carlo treatment planning for proton therapy L. Beaulieu 1, M. Bazalova 2,3, C. Furstoss 4, F. Verhaegen 2,5 (1) Centre.
Introduction Modern radiation therapies such as intensity-modulated radiation therapy (IMRT) and volume modulated arc therapy (VMAT) demand from dose calculation.
At the position d max of maximum energy loss of radiation, the number of secondary ionizations products peaks which in turn maximizes the dose at that.
Dose Distribution and Scatter Analysis
A (Quick) Survey of (Some) Medical Accelerators Dr. Todd Satogata Brookhaven National Laboratory SUNY Stony Brook PHY 684 – September 5, 2007  The NASA.
Radiation and Its Uses Pg Effects of Radiation Radioactive elements are potentially hazardous, but the effects are quite subtle The effects.
Научно-практический центр протонной лучевой терапии и радиохирургии (Москва-Дубна) A SYSTEM FOR MEASUREMENT OF A THERAPEUTIC PROTON BEAM DOSE DISTRIBUTION.
Medical requirements for FFAG as proton beam sources Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE FFAG 2007, April 12-17, 2007.
Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.
G. Bartesaghi, 11° ICATPP, Como, 5-9 October 2009 MONTE CARLO SIMULATIONS ON NEUTRON TRANSPORT AND ABSORBED DOSE IN TISSUE-EQUIVALENT PHANTOMS EXPOSED.
Bragg Peak By: Megan Whitley. Bragg Peak  Bragg Peak is the characteristic exhibited by protons that makes them SO appealing for cancer treatment. 
Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,
Production of innovative radionuclides at ARRONAX and 211 At RIT F. Haddad GIP ARRONAX.
M Asnal *, T Liamsuwan 2 and T Onjun 1 1 Sirindhorn International Institute of Technology, Thammasat University 2 Nuclear Research and Development Division,
THE CHEMICAL CONTEXT OF LIFE. Key Concepts  Matter Consists of chemical elements in pure form and in combinations called compounds.  An elements properties.
ESTRO, Geneva 2003 The importance of nuclear interactions for dose calculations in proton therapy M.Soukup 1, M.Fippel 2, F. Nuesslin 2 1 Department of.
Ultrasound 10cm 2 Ultrasound (US) Therapeutic ultrasound –Uses acoustic energy, delivered at high frequencies for therapeutic purposes Electrical current.
FrontierScience G.P.1 MATRIX an innovative Pixel Ionization Chamber for Online Monitoring of Hadrontherapy Treatments Giuseppe Pittà.
Purpose N-isopropylacrylamide (NIPAM) polymer gel dosimeters were employed to verify the dose distribution of clinical intensity modulated radiation therapy.
Thickness of CZT detector 110 MeV140 MeV DETECTOR A (1 mm CZT + 5 mm CZT) DETECTOR B (1 mm CZT + 10 mm CZT) DETECTOR C (1 mm CZT + 15 mm CZT) A. Generation.
Atoms for Health Prof. Dr. Werner Burkart Skolkovo Conference on: Accelerators and Radiation Technologies for the Future of Russia Saint Petersburg,
Adapting A Clinical Medical Accelerator For Primary Standard Dosimetry
Development of elements of 3D planning program for radiotherapy Graphical editor options  automated enclose of contour  correction of intersections 
12 C fragmentation measurements for hadrontherapy applications Introduction Status French program Japanese-French collaboration.
Achim Stahl RWTH Aachen Hadron Therapy, Jülich Oct, Workshop Nuclear Models for Use in Hadron Therapy October 8./ Achim Stahl – RWTH Aachen.
Monte Carlo methods in spallation experiments Defense of the phD thesis Mitja Majerle “Phasotron” and “Energy Plus Transmutation” setups (schematic drawings)
5.5 Medical Applications Using Radioactivity
Characterization of proton-activated implantable markers for proton range verification using PET J. Cho1, G. Ibbott1, M. Kerr1, R. A. Amos2, F. Stingo1,
J Cho, G Ibbott, M Kerr, R Amos, and O Mawlawi
Methods & Materials (continued)
J Cho, G Ibbott, M Gillin, C Gonzalez-Lepera, U Titt and O Mawlawi
Radioactive Decay Predictions – Chapter 1, Activity 8.
INSTITUTE OF NUCLEAR SCIENCE AND TECHNOLOGY
Understanding Radiation Therapy Lecturer Radiological Science
CT Scan vs MRI.
Proton beam range verification using proton activated fiducials and off-site PET AAPM Best in Physics, Indianapolis, August 7, 2013 Cho J1, Ibbott G1,
INTERCOMPARISON P3. Dose distribution of a proton beam
Radioactive Decay.
Proton range verification with PET: 68Zn, Cu and polycarbonate activation SNMMI Young Investigator Symposium, Vancouver, June 9, 2013 Cho J1, Ibbott.
Khan, The Physics of Radiation Therapy, Ch7
Very High Energy Electron for Radiotherapy Studies
Radioactive Decay.
Development and characterization of the Detectorized Phantom for research in the field of spatial fractionated radiation therapy. D. Ramazanov, V. Pugatch,
Template Matching Can Accurately Track Tumor Evaluation of Dose Calculation of RayStation Planning System in Heterogeneous Media Huijun Xu, Byongyong Yi,
A Brachytherapy Treatment Planning Software Based on Monte Carlo Simulations and Artificial Neural Network Algorithm Amir Moghadam.
M. D. Anderson Cancer Center Houston, TX
Chain Reactions Chain Reaction - the series of repeated fission reactions caused by the release of neutrons in each reaction.
AAPM Annual Meeting, Anaheim, California July 13, 2015
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
PET-utilized proton range verification using 13N signals
OPTICAL MONITORING OF PHOTOSENSITIZER DIFFUSION INTO TISSUE
Isotopes Objectives: 5.2 To identify the advantages & disadvantages of using isotopes in industry, medical science, basic research & in the environment.
The Use of High-Energy Protons in Cancer Therapy
Atoms and Radioactivity
Isotopes Objectives: 5.2 To identify the advantages & disadvantages of using isotopes in industry, medical science, basic research & in the environment.
Innovations in the Radiotherapy of Non–Small Cell Lung Cancer
Sheng Yang a, Yen-Wan Hsueh Liu b
Fundamental Forces of the Universe
Figure 3 Craniospinal irradiation proton therapy for medulloblastoma
Nanoparticles for enhancing the effectiveness of proton therapy
Presentation transcript:

Feasibility of using O-18 for PET proton range verification Cho JM1, Gillin M2, Ibbott GS2, Mawlawi O1. Dept. of Imaging Physics Dept. of Radiation Physics MD Anderson Cancer Center Good afternoon. I am going to talk about the feasibility of using O-18 for PET proton range verification. Since my research is a therapy-imaging hybrid, I am going to go over some basics of proton therapy. Followed by the current method of proton range verification using PET. And then, an innovation made in this research will be presented with the results of experiments I performed at Loma Linda University Proton Center and MD Anderson Cancer Center Proton Center.

Proton Therapy Pros Bragg Peak (BP) No distal dose Cons Range accuracy is critical Range uncertainty up to 10% As you can see from the picture, x-ray beam intensity decreases with depth. Let’s say the tumor is located here. Then, x-ray radiotherapy tends to give higher dose to the normal tissue lying on top of tumor. However, proton therapy has a great characteristic called Bragg Peak. This graph is called pristine Bragg Peak which is from a single proton beam. However, when the proton beams are modulated, we can created a nice spread out Bragg Peak as shown in this graph. This covers tumor with high dose while maintaining low surface dose. Another benefit of the proton therapy is there is no distal dose. To take the best advantage of this Bragg Peak, we need to know the range of the proton beam quite accurately. The current CT based proton treatment plan can created up to 10% of range uncertainty in case of tissue heterogeneity. This uncertainty is not acceptable in case there is a critical organ beyond the tumor.

Proton range verification using PET Planned Dose Measured PET I am going to talk about the current method of proton range verification using PET. MC Dose MC PET Antje-Christin Knopf et al

Proton range verification using PET Planned Dose Measured PET MC Dose MC PET Antje-Christin Knopf et al

Proton range verification using PET 2018-11-19 Proton range verification using PET Dose Dose Activity Activity Antje-Christin Knopf et al

Interaction Cross Sections in Tissue Extremely rare isotope in the body Litzenberg et al

O-18 enriched water Biologically H2O18=H2O16 Precursor for FDG 18F half-life 110 min Extremely rare isotope in the body Litzenberg et al

Measurements & Results (LLUMC)

Measurements & Results (MDACC) 4 different depths 160MeV Proton O16 water O18 water Heptane Empty Plastic water Depth (cm) % Dose Empty C12 O18 O16

Measurements & Results (MDACC) 4 different depths 160MeV Proton O16 water O18 water Heptane Empty Plastic water Depth (cm) PDD (%) dose at depth % Empty C12 O18 O16 96-70% 70-30% 30- 6% 15- 3%

Measurements & Results (MDACC) Depth (cm) PDD (%) dose at depth % Empty 12C 18O 16O 99-87% 87-65% 65-20% 39- 8%

Measurements & Results (MDACC) Depth (cm) PDD (%) dose at depth % Empty 12C 18O 16O 96-70% 70-30% 30- 6% 15- 3%

Conclusion O-18 : strong signal at distal end. O-18 : candidate for proton range verification using PET.

How to obtain O-18? From FDG precursor providers? $20 ~ $100 / gram

How to obtain O-18? From plants? 4~10% enrichment Natural enrichment in plant

Future Research Direction Gel dosimetry study Monte Carlo study O-18 transport study Animal study Affordable O-18

Acknowledgement Authors thank Dr. Schulte at Loma Linda University Medical Center and Dr. Gonzalez-Lepera at CABIR, MD Anderson Cancer Center. Author contact: jcho2@mdanderson.org

Nuclear Interactions of Protons with Tissue 4 most abundant elements Total over 99% 6 most common interactions 16O(p,pn)15O (83.5%) 16O(p,3p4n)10C (4.2%) 16O(p,αpn)11C (2.4%) 12C(p,pn)11C (2.3%) 16O(p,p2n)14O (1.9%) 16O(p,α)13N (1.7%) 16O comprises 94 % Muscle Adipose Oxygen 72.9 % 27.8 % Carbon 12.3 % 59.8 % Hydrogen 10.2 % 11.4 % Nitrogen 3.5 % 0.7 % Litzenberg et al

Discussion At COM, 16O water initially gave high signal but after 20 minutes, 18O water signal was stronger. At Distal end, 18O water was strongest over the entire time. After 20 minutes, 16O water was at noise level. 18O water shows stronger PET signals in both COM and distal end. 16O signal was noise at distal end. Even diluted 10% 18O water gave more signal than 16O in both Gamma Camera and PET.

In-vivo dosimetry using PET 2018-11-19 In-vivo dosimetry using PET Proton beam Water in tissue Daughter product p ~> + 16O → 15O + p + n decay 15N (stable) + e+ combine e- → PET 0.511 MeV 0.511 MeV

Proton range verification using PET Planned Dose Measured PET MC Dose MC PET Antje-Christin Knopf et al

Bragg-Peak Review Most protons < 10 MeV with max ~ 30 MeV Proton at few MeV

Overview Proton Therapy Proton Range Verification using PET Purpose 2018-11-19 Overview Proton Therapy Proton Range Verification using PET Purpose Properties of O-18 Method and Materials Results Conclusion Future Direction

O-18 enriched water Biologically O-18 water = O-16 water Precursor for FDG -18O(p,n)18F Cross section threshold 2.6 MeV and maximum 5 MeV 18F half-life 110 min

O-18 enriched water Biologically O-18 water = O-16 water Precursor for FDG -18O(p,n)18F Cross section threshold 2.6 MeV and maximum 5 MeV 18F half-life 110 min Litzenberg et al

Material and Methods

Results – Gamma Camera at COM

Results – Gamma Camera at distal end

Results – PET Axial COM PET axial images Distal end PET axial images Images taken over 60 minutes 98% O18 10% O18 100% O16

Method & Materials (LLUMC)

Results (LLUMC) 98% O18 10% O18 100% O16

Results (MDACC)